EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s Disease

Mona Abdelhamid, Scott E Counts, Chunyu Zhou, Hideki Hida, Jae-Il Kim iD, Makoto Michikawa iD, Cha-Gyun Jung iD

Nutrients · 31.01.2025 · 17 (3) · 558

DOI: 10.3390/nu17030558 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 31.01.2025. Verfasst von Mona Abdelhamid und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Neuroscience, College of Human Medicine, Michigan State University, 400 Monroe Avenue NW, Grand Rapids, MI 49503, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Probiotics, Bifidobacterium breve. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant-in-Aid for Scientific Research, AMED, Ministry of Education, Culture, Sports, Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is the most common form of dementia and is characterized by memory impairment that significantly interferes with daily life. Therapeutic options for AD that substantively modify disease progression remain a critical unmet need. In this regard, the gut microbiota is crucial in maintaining human health by regulating metabolism and immune responses, and increasing evidence suggests that probiotics, particularly beneficial bacteria, can enhance memory and cognitive functions. Recent studies have highlighted the positive effects of Bifidobacterium breve MCC1274 (B. breve MCC1274) on individuals with mild cognitive impairment (MCI) and schizophrenia. Additionally, oral supplementation with B. breve MCC1274 has been shown to effectively prevent memory decline in AppNL–G–F mice. In relation to Alzheimer’s pathology, oral supplementation with B. breve MCC1274 has been found to reduce amyloid-β (Aβ) accumulation and tau phosphorylation in both AppNL–G–F and wild-type (WT) mice. It also decreases microglial activation and increases levels of synaptic proteins. In this review, we examine the beneficial effects of B. breve MCC1274 on AD, exploring potential mechanisms of action and how this probiotic strain may aid in preventing or treating the disease. Furthermore, we discuss the broader implications of B. breve MCC1274 for improving overall host health and provide insights into future research directions for this promising probiotic therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseProbioticsBifidobacterium breveHumansAnimalsGastrointestinal MicrobiomeMiceAmyloid beta-PeptidesDisease Models, AnimalCognitive Dysfunction

Stichwörter der Autor:innen

Alzheimer’s diseaseBifidobacterium breve MCC1274amyloid-βglial activationsynapsestau phosphorylation

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Translational Neuroscience, College of Human Medicine, Michigan State University, 400 Monroe Avenue NW, Grand Rapids, MI 49503, USA.
  • Department of Biochemistry, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
  • Department of Neurophysiology and Brain Science, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.
  • Department of Food Science and Nutrition, Pukyong National University, Busan 48513, Republic of Korea.
  • Department of Geriatric Medicine, School of Life Dentistry at Niigata, Nippon Dental University, Niigata 951-8580, Japan.
  • Center for Nursing International Promotion, Nagoya City University Graduate School of Nursing, Nagoya 467-8601, Japan.

ORCID-Profile: Jae-Il Kim, Makoto Michikawa, Cha-Gyun Jung

Förderung

  • Grant-in-Aid for Scientific Research
  • AMED
  • Ministry of Education, Culture, Sports, Science

Zitieren

APA

Abdelhamid, M., Counts, S. E., Zhou, C., Hida, H., Kim, J. I., Michikawa, M., & Jung, C. G. (2025). Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s Disease. Nutrients, 17(3), 558. https://doi.org/10.3390/nu17030558

Vancouver

Abdelhamid M, Counts SE, Zhou C, Hida H, Kim JI, Michikawa M, et al. Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s Disease. Nutrients. 2025;17(3):558. doi:10.3390/nu17030558

BibTeX
@article{Abdelhamid2025,
  author = {Abdelhamid, Mona and Counts, Scott E and Zhou, Chunyu and Hida, Hideki and Kim, Jae-Il and Michikawa, Makoto and Jung, Cha-Gyun},
  title = {Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s Disease},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {3},
  pages = {558},
  doi = {10.3390/nu17030558}
}
Kostenlos starten →